NON-CONTROLLING INTEREST (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2024

Dec. 31, 2023

Noncontrolling Interest [Abstract]

SCHEDULE OF NON CONTROLLING INTEREST

	September 30, 2024		December 31, 2023
Net loss Subsidiary	$	n/a	$	(333,630	)
Net loss attributable to the non-controlling interest		n/a		90,258
Net loss affecting Bioxytran		n/a		(243,372	)
Accumulated losses		n/a		(3,927,917	)
Accumulated losses attributable to the non-controlling interest		n/a		841,836
Accumulated losses affecting Bioxytran		n/a		(3,086,081	)
Net equity non-controlling interest	$	n/a	$	(680,886	)

	December 31, 2023			December 31, 2022
Net loss Subsidiary	$	(333,630	)	$	(817,151	)
Net loss attributable to the non-controlling interest		90,258			193,372
Net loss affecting Bioxytran		(243,372	)		(623,780	)
Accumulated losses		(3,927,917	)		(3,594,287	)
Accumulated losses attributable to the non-controlling interest		841,836			751,578
Accumulated losses affecting Bioxytran		(3,086,081	)		(2,842,709	)
Net equity non-controlling interest	$	(680,886	)	$	(590,628	)